Clinical Trial Update: XIENCE 28 Global Study [NA]

View source ↗

Summary

Clinical trial update for the XIENCE 28 Global Study is completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Blood Disorders
• Coagulation Disorders
• Coronary Artery Disease
• Hematological Disease
• Renal Insufficiency
• Stroke
• Thrombocytopenia

Drugs mentioned

• XIENCE 28 Global Study

Snippet

Sponsor: Abbott Medical Devices | Conditions: Bleeding Disorder, Stroke, Ischemic | NA | Status: COMPLETED | Results posted: 2021-02-08